Skip to main content

Tourmaline Bio, Inc.

TRMLDelisted Oct 28, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827506

Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.

Holders of 5% or more of TRML

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tourmaline Bio, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TRML
HolderLatest formStakeChangeFirst filedLatest filingFiling
Avoro Capital Advisors LLC13G/A9.95%2.56M shares–Nov 14, 20242 filingsAug 14, 2025SEC
QVT Financial LP13G/A8.39%2.15M shares+2.65 ppfrom 5.74%May 15, 20252 filingsAug 14, 2025SEC
BlackRock, Inc.13G/A5.50%1.41M shares–Oct 22, 20243 filingsOct 17, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

40 Schedule 13D and 13G filings on Tourmaline Bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TRML
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20254:19 PM ETRa Capital Management, L.P.and 3 others13G/A0.00%0 shares–Below 5%Sep 30, 2025SEC
Oct 17, 20256:24 PM ETBlackRock, Inc.13G/A5.50%1.41M shares–Sep 30, 2025SEC
Aug 14, 20254:00 PM ETQVT Financial LP13G/A8.39%2.15M shares+2.65 ppfrom 5.74%Jun 30, 2025SEC
Aug 14, 20257:04 AM ETAvoro Capital Advisors LLCand 1 other13G/A9.95%2.56M shares–Jun 30, 2025SEC
May 15, 20254:22 PM ETQVT Financial LP13G5.74%1.47M sharesNewMar 31, 2025SEC
Feb 14, 20255:09 PM ETBlue Owl Capital Holdings LP13G/A4.20%1.08M shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Deep Track Capital, LP13G/AOld format–––SEC
Nov 14, 2024Blue Owl Capital Holdings LP13G/AOld format–––SEC
Nov 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Nov 14, 2024Viking Global Investors LPSuperinvestorViking Global Investors13G/AOld format–––SEC
Nov 14, 2024Avoro Capital Advisors LLC13GOld format–New–SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 22, 2024BlackRock, Inc.13GOld format–New–SEC
Jun 3, 2024Ra Capital Management, L.P.13GOld format–––SEC
Mar 15, 2024Pfizer Inc13G/AOld format–––SEC
Feb 14, 2024Blue Owl Capital Holdings LP13GOld format–New–SEC
Feb 14, 2024Hydra LLC13G/AOld format–––SEC
Feb 14, 2024Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2024Citadel Advisors LLC13G/AOld format–––SEC
Feb 9, 2024Blackstone Holdings II L.P.13G/AOld format–––SEC
Feb 9, 2024TCG Crossover GP I, LLC13GOld format–New–SEC
Feb 7, 2024BML Investment Partners, L.P.13G/AOld format–––SEC
Nov 6, 2023Hydra LLC13GOld format–New–SEC
Oct 30, 2023Longitude Capital Partners III, LLC13D/AOld format–––SEC
Oct 30, 2023Qiming U.S. Healthcare GP II, LLC13D/AOld format–––SEC
Oct 27, 2023Deep Track Capital, LP13GOld format–New–SEC
Oct 27, 2023Pfizer Inc13GOld format–New–SEC
Jul 6, 2023Ra Capital Management, L.P.13GOld format–New–SEC
Apr 27, 2023BML Investment Partners, L.P.13GOld format–––SEC
Apr 27, 2023BML Investment Partners, L.P.13GOld format–New–SEC
Feb 14, 2023Citadel Advisors LLC13G/AOld format–––SEC
Aug 9, 20224:02 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 28, 2022Qiming U.S. Healthcare GP II, LLC13DOld format–New–SEC
Feb 14, 2022Viking Global Investors LPSuperinvestorViking Global Investors13G/AOld format–––SEC
Feb 14, 2022Citadel Advisors LLC13G/AOld format–––SEC
Feb 11, 2022Blackstone Holdings II L.P.13GOld format–New–SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
May 21, 2021Longitude Capital Partners III, LLC13DOld format–New–SEC
May 21, 2021Citadel Advisors LLC13GOld format–New–SEC
May 17, 2021Viking Global Investors LPSuperinvestorViking Global Investors13GOld format–New–SEC

Form 144: proposed insider sales

4 notices from officers, directors and other affiliates planning to sell Tourmaline Bio, Inc. shares, newest first.

Form 144 notices for TRML
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jul 5, 20235:10 PM ETRequadt ScottFormer Officer and Director11.8K$36.3KJul 5, 2023Fidelity Brokerage Services LLCSEC
Jul 5, 20234:52 PM ETFenton Mary KayOfficer12.9K$39.9KJul 5, 2023Fidelity Brokerage Services LLCSEC
Jun 1, 20234:21 PM ETSuzanne IldstadDirector250.0K$662.5KJun 1, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 21, 20234:32 PM ETSuzanne IldstadOfficer10.1K$24.0KApr 21, 202310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC